Navigation Links
Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
Date:12/16/2009

NEW YORK, Dec. 16 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today the initiation of a Phase 3 registration clinical trial for KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor, in relapsed / refractory multiple myeloma patients.

The trial, entitled, "A Phase 3 Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib (Velcade®) and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib" is a double-blind, placebo-controlled trial comparing the efficacy and safety of perifosine vs. placebo when combined with bortezomib (Velcade®) and dexamethasone. The trial will enroll approximately 400 patients with relapsed or relapsed / refractory multiple myeloma. The primary endpoint is progression-free survival and secondary endpoints include overall response rate, overall survival and safety. This trial is being conducted pursuant to a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA). Additionally, the FDA has granted perifosine Orphan Drug and Fast Track designations in this indication.

The Phase 3 trial is being led by the Principal Investigator, Dr. Paul Richardson, Clinical Director of the Jerome Lipper Multiple Myeloma Center, at Dana-Farber Cancer Institute (DFCI) in Boston, MA and Dr. Kenneth C, Anderson, Chief, Division of Hematologic Neoplasia at DFCI. An estimated 40 to 50 centers throughout the United States and select centers outside of the United States will be participating in this Phase 3 trial.

Dr. Richardson's clinical research focuses on studying novel therapies for multiple myeloma. He was the lead investigator of the

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , September 30, 2014 In ... CSF (Cerebrospinal Fluid) backflow of the Eldor spinal needle ... the single hole pencil point spinal needles of the ... Spinal anesthesia is an excellent type of ... Urology, General Anesthesia, etc. It is estimated ...
(Date:9/30/2014)... Sept. 30, 2014  The orthopedic specialists at Midwest ... 6 orthopedic group by US News & World Report, ... series of free, public seminars to discuss partial and ... world come to see the knee physicians at Midwest ... available at Munster Specialty Surgery Center. ...
(Date:9/30/2014)... 2014  Arena Solutions, the pioneer of cloud-based ... Fall 2014 release, which includes two new modules ... DataExtract – and significant enhancements to ... focused specifically on speeding time to market. They ... complete history of tribal knowledge throughout the supply ...
Breaking Medicine Technology:"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 2Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 3Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 4
(Date:10/1/2014)... Looking for holiday gift ideas? Éminence Organic Skin Care, ... easy this holiday season. Starting October 1st 2014, new spa ... shopping dilemmas. Choose from two luxury skin care gift sets ... eye area or to deliver whole body beauty. , ... Gift Set are formulated to suit all skin types and ...
(Date:10/1/2014)... 01, 2014 The annual Social Security cost-of-living ... 2015, says a new forecast by The Senior Citizens ... price index (CPI) data through August, TSCL forecasts that COLAs ... the sixth consecutive year of record low COLAs,” states TSCL ... became automatic in 1975,” he notes. , Over the past ...
(Date:10/1/2014)... Nearly a year-and-a-half after filing his ... Court jury awarded him $4.75 million; Michael D. Casper ... Casper had been too sick to be present ... the Court Documents (District Court, Pueblo County 12CV740,  Division ... non-cancerous condition of his prostate, when he purchased a ...
(Date:9/30/2014)... medical and nursing students in developing countries may have ... graduation, while less than one fifth of them intend ... most, according to a new study. , Health workforce ... outbreak of Ebola in western Africa. The disease initially ... world,s poorest countries (Guinea, Sierra Leone and Liberia), where ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- Children conceived either less than ... of a sibling could be at increased risk for autism, ... author and an outside expert agree that the research can,t ... "Most importantly, it is important that parents understand that ... pregnancies are close together or far apart," said outside expert ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 2Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 3Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 3Health News:Law Offices of D.R. Jones Client Wins 4.7 Million Dollar Verdict, Insurance Company Files Motion for a New Trial 2Health News:Law Offices of D.R. Jones Client Wins 4.7 Million Dollar Verdict, Insurance Company Files Motion for a New Trial 3Health News:Developing countries should enroll medical and nursing students from rural areas 2Health News:Developing countries should enroll medical and nursing students from rural areas 3Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2
... A quick, painless eye measurement shows promise as a ... stages, and to track the effectiveness of treatments, researchers ... multicenter study. "This technique has the potential to ... structural changes in the central nervous system, both for ...
... has appointed V. Craig Jordan, OBE, PhD, DSc, FMedSci, to ... National Academy of Sciences, is the scientific director and vice ... Cancer Center at Georgetown University Medical Center. ... is reserved for those who have a distinguished record of ...
... , ANN ARBOR, Mich. A drug designed to target ... type of blood cancer. A multi-center study looked at ... CS1, a protein on the surface of malignant plasma cells. ... cells and eliminates them by an immune mechanism. The early ...
... order super-premium vodka in every martini or vodka-and-cranberry, and disdain ... pay $60 for a bottle of a "tasteless" beverage that ... is there really a scientific basis for the differences that ... Scientists are reporting the first identification of a ...
... and animals are very different organisms, they share a surprising ... University says that one of these mechanisms may be the ... Prof. Shaul Yalovsky, of the Molecular Biology and Ecology of ... that can turn on cell growth in plants. Now, in ...
... cancer may be at increased risk for having a ... by St. Jude Children,s Research Hospital investigators. Almost ... Study (CCSS) who were diagnosed with basal or squamous ... 15 years, said Gregory Armstrong, M.D., assistant member of ...
Cached Medicine News:Health News:Simple eye test measures damage from multiple sclerosis, UT Southwestern researchers find 2Health News:Susan G. Komen for the Cure awards grant to Lombardi's V. Craig Jordan 2Health News:Susan G. Komen for the Cure awards grant to Lombardi's V. Craig Jordan 3Health News:Susan G. Komen for the Cure awards grant to Lombardi's V. Craig Jordan 4Health News:Brand preference may be in the drink, not in the head 2Health News:A turn-off for cancer 2Health News:Non-melanoma skin cancer may help identify survivors at increased risk for future cancers 2
Fully automatic NRTL and CE certified microplate reader....
... microplate reader for fluorescence and absorbance ... on superior performance in both detection ... luminescence measurements. Synergy HT with 4 ... 5 mm bottom probe, incubation to ...
Diareader ELX800G...
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
Medicine Products: